Faculty Bibliography

In less than two hours, while [Dick Cheney] slept under mild sedation, his doctors concluded that his heart was susceptible to abnormal, rapid heartbeats and installed the device as what they and Cheney called 'an insurance policy.' By lunchtime, Cheney was awake, eating and talking with President Bush, who called from Camp David in Maryland. [Jonathan Reiner] said he had been explicit in telling Cheney, 60, that 'this procedure and this device would not in any way impair his ability' to perform his duties. That was significant because while announcing Friday that he would receive the implant, Cheney said that his continued service as vice president was in the hands of his doctors. Assuming that Cheney's disease proves manageable for the next three years, the big political decision for Bush would come in 2004, when he would have to decide whether Cheney once again should be his running mate. But by that time, Cheney may not be needed to establish maturity and credibility for Bush, as he did last year

[Jonathan Reiner] said he had been explicit in telling [Dick Cheney], 60, that 'this procedure and this device would not in any way impair his ability' to perform his duties. Cheney has been hospitalized three times since November. He suffered a minor heart attack during the recount that followed the presidential election, and doctors installed a wire mesh stent to keep a clogged coronary artery open. That artery narrowed again, requiring another procedure to reopen it in March. Assuming that Cheney's disease proves manageable for the next three years, the big political decision for [Bush] would come in 2004, when he would have to decide whether Cheney should once again be his running mate

Whether the device that was implanted near [Dick Cheney]'s left shoulder will prevent him from casting with his right arm this week is uncertain. Saturday, Dr. Jonathan S. Reiner, Cheney's cardiologist, said his team had advised Cheney against vigorous upper- body exercise 'for the next several days certainly, and maybe the next couple of weeks.'

[Jonathan Reiner] said his team wanted [Dick Cheney] to continue his regular aerobic exercising. The temporary ban on upper-body exercise is to provide enough time for the device, known as an implantable cardioverter defibrillator, or ICD, to settle in place near his left shoulder, and for the incision to heal. It will take several weeks for Cheney's body to form the scar tissue that will secure the device. Cheney needed the device because an electrocardiogram test performed two weeks ago detected four episodes of a very rapid and potentially fatal heart rhythm known as ventricular tachycardia, which stopped on their own after two seconds or less

Whether the device that was implanted near Mr. [Dick Cheney]'s left shoulder will prevent him from casting with his right arm this week is uncertain. At a news conference on Saturday, Dr. Jonathan S. Reiner, Mr. Cheney's cardiologist, said his team had advised Mr. Cheney against vigorous upper body exercise ''for the next several days certainly, and maybe the next couple of weeks.'' Dr. Reiner said his team wanted Mr. Cheney to continue his regular aerobic exercising. The temporary ban on upper body exercise is to provide enough time for the device, known as an implantable cardioverter defibrillator, or I.C.D., to settle in place near his left shoulder and for the incision to heal. It will take several weeks for Mr. Cheney's body to form the scar tissue that will secure the device, a model known as Medtronic GEM III DR

Johns Hopkins officials have questioned whether FDA approval was required for the asthma study; nonetheless, they said they have temporarily halted any studies involving drugs for which the FDA has not given permission for experimental use until they consult with the drug agency. The FDA licensed hexamethonium as a pill for treatment of high blood pressure in the 1950s, but the manufacturer withdrew it from the market in the 1970s after new laws required that drugs meet both safety and effectiveness standards instead of the earlier standard of safety, said Dr. David Lepay, an FDA official. Johns Hopkins officials last night said the researcher who led the study, Dr. Alkis Togias, and the review board did not believe that they needed FDA approval for inhaled hexamethonium because it was being used for basic physiology tests and not to test its therapeutic value

One thing few doctors considered was the possibility of new infectious agents. We had been taught, quite arrogantly, that virtually all diseases were known; it was just that many things were unknown about them. In fact, an editorial in The New England Journal of Medicine in December 1981 on possible causes of AIDS omitted the whole idea that AIDS might be caused by a previously unknown infectious agent. In Zambia, I hid in the back of a car to escape an angry crowd that did not want journalists reporting on the disease in their country. Earlier, I had tried to interview the country's president, Kenneth Kaunda, about AIDS. His press secretary refused, screaming that reporters only wanted to blame Africa for unleashing the disease on the world when, in his opinion, Americans had brought the disease to Africa. Years later, Mr. Kaunda talked about losing a son to AIDS and the cost of delayed recognition of the AIDS problem. By now, I have written more than 500 articles about AIDS. Tens of millions of sons and daughters are infected, and millions more are AIDS orphans. Last week's special session on AIDS at the United Nations was the first time the General Assembly ever met to address any health issue, and there was a growing realization that the joining of scientific skill and political will holds the best promise for controlling a disease that was unknown until 20 years ago

Johns Hopkins officials have questioned whether F.D.A. approval was required for the asthma study. Nonetheless, they said they had temporarily halted any studies involving drugs the agency had not approved for experimental use until they consult with the agency. The F.D.A. licensed hexamethonium as a pill for treatment of high blood pressure in the 1950's, but the manufacturer withdrew it from the market in the 1970's after new laws required that drugs meet both safety and effectiveness standards instead of the earlier standard of safety, said Dr. David Lepay, an F.D.A. official. The F.D.A. said that when the first volunteer in the asthma study developed a persistent cough two days after inhaling hexamethonium on April 23, Dr. [Alkis Togias]'s team at Johns Hopkins failed to notify the university's institutional review board. The cough lasted from April 25 to May 3, the F.D.A. said

The first recipient of a self-contained artificial heart was alert and doing well, said Dr. Laman H. Gray Jr., one of his surgeons in Louisville, Ky. ''He looks good,'' Dr

An unidentified diabetic man in his 50's became the first human to live with a self-contained artificial heart